,0
symbol,IQV
price,242.98
beta,1.457352
volAvg,1167918
mktCap,46388527104
lastDiv,0.0
range,206.69-285.61
changes,-9.309998
companyName,IQVIA Holdings Inc.
currency,USD
cik,0001478242
isin,US46266C1053
cusip,46266C105
exchange,New York Stock Exchange
exchangeShortName,NYSE
industry,Diagnostics & Research
website,https://www.iqvia.com
description,"IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina."
ceo,Mr. Ari Bousbib
sector,Healthcare
country,US
fullTimeEmployees,79000
phone,19199982000
address,4820 Emperor Blvd
city,Durham
state,NORTH CAROLINA
zip,27703
dcfDiff,7.14062
dcf,250.121
image,https://financialmodelingprep.com/image-stock/IQV.png
ipoDate,2013-05-09
defaultImage,False
isEtf,False
isActivelyTrading,True
isAdr,False
isFund,False
